Department of Health and Human Services

Part 1. Overview Information

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

Office of AIDS Research (OAR)

Funding Opportunity Title
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)
Activity Code
C06 Research Facilities Construction Grant
Announcement Type
Related Notices
  • May 5, 2021 - This PAR has been reissued as PAR-21-238.
  • April 29, 2021 - Notice of Early Termination of PAR-21-159. See Notice NOT-OD-21-112.
Funding Opportunity Announcement (FOA) Number
Companion Funding Opportunity
Number of Applications

See Section III. 3. Additional Information on Eligibility.

Assistance Listing Number(s)
Funding Opportunity Purpose

This Funding Opportunity Announcement (FOA) invites applications from qualified research institutions to seek funds to develop or renovate research facilities that support HIV/AIDS research in areas of basic, translational, clinical, and social and behavioral science research. Targeted are institutions that serve underrepresented and underserved populations or that are in Institutional Development Award (IDeA)-eligible states. Research-intensive institutions are not eligible. The facilities must support research aligned with the NIH-established priorities for HIV/AIDS research. Any request must be justified by current and anticipated future research needs.

Key Dates

Posted Date

April 12, 2021

Open Date (Earliest Submission Date)
December 06, 2021
Letter of Intent Due Date(s)

December 01, 2021

Application Due Dates Review and Award Cycles
New Renewal / Resubmission / Revision (as allowed) AIDS Scientific Merit Review Advisory Council Review Earliest Start Date
Not Applicable Not Applicable January 06, 2022 February-April 2022 May 2022 July 2022

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date
New Date May 4, 2021 per issuance of NOT-OD-21-112. (Original Expiration Date: January 07, 2022 )
Due Dates for E.O. 12372

As described in the NIH Grants Policy Statement, an applicant must provide a copy of the application to the State Single Point of Contact (SPOC) no later than the time the application is submitted to NIH. SPOC comments must be submitted to NIH with the application, or the application must indicate the date on which the application was provided to the SPOC for review.

Required Application Instructions

It is critical that applicants follow the instructions in the Research (R) Instructions in the SF424 (R&R) Application Guide, except where instructed to do otherwise (in this FOA or in a Notice from NIH Guide for Grants and Contracts).

Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions.

Applications that do not comply with these instructions may be delayed or not accepted for review.

Table of Contents

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

This Funding Opportunity Announcement (FOA) invites applications from qualified institutions to seek support for the development of modern facilities that will enable and enhance the conduct of cutting-edge biomedical and behavioral research on HIV/AIDS. Any facility supported by this FOA must serve a broad research community locally or regionally. Targeted are basic, translational, clinical, and social and behavioral science research facilities that serve underrepresented and underserved populations or are located in IDeA-eligible states. For additional eligibility conditions check Section III.3.

The NIH-established priorities for HIV/AIDS research, detailed on the Office of AIDS Research (OAR) website, encompass several areas of research, including activities directed towards:

  • Reduce the Incidence of HIV, including supporting the development of safe and effective vaccines, microbicides and pre-exposure prophylaxis.
  • Develop Next-Generation HIV Therapies with improved safety and ease of use.
  • Conduct Research Toward HIV Cure.
  • Address HIV-Associated Comorbidities, Coinfections, and Complications through research designed to decrease and/or manage these conditions.
  • Advance Cross-Cutting Areas of research in the basic sciences, behavioral and social sciences, epidemiology, implementation science, information dissemination, and research training.

NIH recognizes that modern physical infrastructure is necessary for the conduct of cutting-edge research. Dedicated space is required to house specialized equipment and to carry out experimental protocols. The scope of individual applications will vary and depend on the currently available infrastructure at the applicant institution, as well as the present and anticipated HIV/AIDS research needs. Requests must be justified by the needs for advancement of HIV/AIDS research. Focusing on the advancement of basic biology discoveries, the development of diagnostic tools and therapies, or advancing prevention and treatment through clinical and biobehavioral research will be a common and integral part of any project’s justification. The project, when completed, is expected to provide significant long-term institution-wide support for HIV/AIDS research, bringing the capacities and capabilities to a new level. Consequently, the applicant institution should demonstrate future-looking commitments towards the facility and HIV/AIDS research therein, by attaching a letter of support from a high-ranking institutional official.

This FOA is limited to projects from institutions that serve underrepresented and underserved populations or are located in IDeA-eligible states/jurisdictions -See Section III.3. NIH recognizes the importance of these institutions in contributing to the nation’s HIV/AIDS research capacity. Such institutions often serve as centers for dissemination of health information, training development, and advancement of research in areas especially affected by the HIV/AIDS epidemic. A successful project will provide space that will be used on a shared basis in supporting well specified efforts in HIV/AIDS research.

For applications submitted to this FOA, it is expected that each project will implement the best engineering solutions and modern technologies. Some HIV/AIDS research protocols require BSL-3 facilities, while others can be carried out in BSL-2 or BSL-1 spaces. Specific requested engineering solutions will be driven by research demands, such as the need to create shielded space to house certain equipment or to meet privacy and human subjects needs of biobehavioral or clinical work.

Requests for regular maintenance, replacement of aging or failing equipment, and other routine work are not appropriate for this FOA. Also inappropriate are requests for upgrades of a space serving a single investigator, facilities for billable medical care, office space, and classrooms. Such inappropriate requests will not be supported.

Applicants may request funds to cover design and implementation costs of the project. Specifically, the allowable costs include the architectural and engineering design fees, contingency fees, construction and fixed equipment expenses, and fees for commissioning of the facility. See the Funding Restrictions section for further details on allowable and non-allowable costs. Applicants are encouraged to follow sustainable design principles and to use green technologies.

To appropriately conceive, develop, construct, and successfully complete the project, a Program Director/Principal Investigator (PD/PI) should possess knowledge of the HIV/AIDS research field, have a vested professional interest in the success of the project, demonstrate leadership skills, and assemble a team with technical expertise related to all aspects of the project. The PD/PI does not need to be a currently NIH-funded investigator but should have the appropriate standing in the institutional administration and the research community to lead and oversee the project.

The project should meet the following criteria and documentation requirements:

The project is essential to the support of high priority HIV/AIDS-related research activities.

The facility must have a useful life of 20 years or longer following occupancy, consistent with program purposes, including the time to construct and complete the project;

For modernization and renovation projects, the structure must be architecturally and physically suitable for conversion to the type of research space required.

If the space is rented, evidence must be provided that the terms of the lease and expected subsequent use of the facility are consistent with the proposed project. Specifically, a signed document from the building owner must be provided, detailing that the terms of the lease agreement and subsequent use of the facility will comply with the 20-year term of the Notice of Federal Interest (NFI) requirement following the occupancy of the facility. A statement of agreement by the owner of the space must be included at the time of application submission. These documents will be verified if/when the application is considered for funding.

If the project will affect a site listed (or eligible for inclusion) in the National Register of Historic Places, the requirements specified in "Preservation of Cultural and Historic Resources" must be followed.

Funding for awards will be allocated by OAR and administered by ORIP. See Section VII. Other Information for award authorities and regulations.

See Section VIII. Other Information for award authorities and regulations.

Section II. Award Information

Funding Instrument

Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.

Application Types Allowed

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA.

Funds Available and Anticipated Number of Awards

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Award Budget

Application budget should reflect the actual needs of the proposed project. The maximum award is $2,000,000. Applications with budgets less than $500,000 will not be considered. The size of the award will be dependent on the scope of the project.

Award Project Period

The total project period shall not exceed five years. Funds will be provided in a single award with up to a 60-month budget and project period.
Architectural and engineering design fees are immediately available to applicants at the time of the Notice of Award (NoA); all other award funds are restricted until Office of Research Infrastructure Programs (ORIP) approves the design documents; upon approval, the NIH will issue a revised NoA to release the restricted award funds.

NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this FOA.

Section III. Eligibility Information

1. Eligible Applicants

Eligible Organizations

Higher Education Institutions

  • Public/State Controlled Institutions of Higher Education
  • Private Institutions of Higher Education

The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:

  • Hispanic-serving Institutions
  • Historically Black Colleges and Universities (HBCUs)
  • Tribally Controlled Colleges and Universities (TCCUs)
  • Alaska Native and Native Hawaiian Serving Institutions
  • Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

Nonprofits Other Than Institutions of Higher Education

Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)

Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

To be eligible for this FOA, the applicant institution must be a domestic institution located in the United States and its territories which:

Has received an average of less than $50 million per year of NIH support for the past three fiscal years

Awards doctorate degrees in the health professions or the sciences related to health; and

Is located in IDeA states (IDeA-eligible states/jurisdictions) or serves underrepresented and underserved populations. Institutions serving underrepresented and underserved populations must have a historical and current mission to educate students from any of the populations that have been identified as underrepresented in biomedical research as defined by the National Science Foundation NSF, see (i.e., African Americans or Blacks, Hispanic or Latino Americans, American Indians, Alaska Natives, Native Hawaiians, U.S. Pacific Islanders, and persons with disabilities) or has a documented record of: (1) recruiting, training and/or educating, and graduating underrepresented students as defined by NSF (see above), which has resulted in increasing the institution's contribution to the national pool of graduates from underrepresented backgrounds who pursue biomedical research careers and, (2) for institutions that deliver health care services, providing clinical services to medically underserved communities.

  • Research-intensive institutions are not eligible to apply.

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Required Registrations

Applicant organizations

Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.

  • Dun and Bradstreet Universal Numbering System (DUNS) - All registrations require that applicants be issued a DUNS number. After obtaining a DUNS number, applicants can begin both SAM and eRA Commons registrations. The same DUNS number must be used for all registrations, as well as on the grant application.
  • System for Award Management (SAM) Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code.
  • eRA Commons - Applicants must have an active DUNS number to register in eRA Commons. Organizations can register with the eRA Commons as they are working through their SAM or registration, but all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application.
  • Applicants must have an active DUNS number and SAM registration in order to complete the registration.

Program Directors/Principal Investigators (PD(s)/PI(s))

All PD(s)/PI(s) must have an eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.

Eligible Individuals (Program Director/Principal Investigator)

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director/Principal Investigator (PD/PI) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.

Multiple PDs/PIs are not allowed.

The PD/PI should hold appropriate stature within the institutional administration structure and HIV/AIDS research community to be able to oversee various facets of the entire project.

The PD/PI should also have a demonstrated record of leadership skills to recruit and guide expert Key Personnel with complementary technical and scientific skills to successfully accomplish the construction project.

For the description of roles of Key Personnel see Section Senior/Key Person Profile Expanded.

2. Cost Sharing

This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.

3. Additional Information on Eligibility

Number of Applications

Only one application per institution (identified by NIH IPF number) is allowed.

The NIH will not accept duplicate or highly overlapping applications under review at the same time. This means that the NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).

Section IV. Application and Submission Information

1. Requesting an Application Package

The application forms package specific to this opportunity must be accessed through ASSIST, Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Workspace are available in Part 1 of this FOA. See your administrative office for instructions if you plan to use an institutional system-to-system solution.

2. Content and Form of Application Submission

It is critical that applicants follow the instructions in the Research (R) Instructions in the SF424 (R&R) Application Guide except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

Letter of Intent

Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.

By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:

  • Descriptive title of proposed activity
  • Name(s), address(es), and telephone number(s) of the PD/PI
  • Names of other key personnel
  • Participating institution(s)
  • Number and title of this funding opportunity

The letter of intent should be sent to:

Guanghu Wang, Ph.D., M.B.A.
Office of Research Infrastructure Programs (ORIP)
Telephone: 301-435-0772

Page Limitations
All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

The following exceptions or additional requirements apply:

  • For this FOA, there is no Research Strategy
  • The Project Narrative attachment of the SF424 (R&R) Other Project Information form is limited to 12 pages, excluding Line Drawings and specifically required Tables. These Line Drawings and required Tables are to be included in the Other Attachments section, and do not count against the 12-page limit for the Project Narrative attachment.
Instructions for Application Submission

The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing an application to this FOA.

SF424(R&R) Cover

All instructions in the SF424 (R&R) Application Guide must be followed.

The following additional instructions apply:

Estimated Project Funding: Applicants must provide the 'Total Federal Funds Requested', 'Total Federal and Non-Federal Funds', and 'Estimated Program Income .

Is Application Subject to Review by State Executive Order 12372 Process: Applicants should indicate "yes" and provide the date the application was submitted to the State.
SF424(R&R) Project/Performance Site Locations

All instructions in the SF424 (R&R) Application Guide must be followed.

SF424(R&R) Other Project Information

All instructions in the SF424 (R&R) Application Guide must be followed.

Project Narrative: (to be assembled in order shown below): The Project Narrative should consist of three sections: Overview, Scientific Justification, and Development of the Facility, and should be submitted as a single PDF attachment.

The Overview section (in lieu of Specific Aims): This section cannot exceed one page and must summarize the project, stating its goals and outlining the proposed approaches to achieve them. This section should include a brief description of the current operations of the space and its physical infrastructure, as relevant to this project. Tables 1 and 2 in the Other Attachments section may be referenced to simplify the description of the space affected by the proposed project and the requested fixed equipment. This section should state how the proposed project activities will advance HIV/AIDS research, aligned with the NIH-established priorities, at the applicant institution or regionally Table 3 in Other Attachments may be referenced.

A timeline for different stages of the project and its completion within the sixty-month budget period must be included in Other Attachments and can be used as a refenced in this section.

It is up to the PD/PI to allocate the remaining 11 pages of the Project Narrative to the sections of Scientific Justification and Development of the Facility. A successful application does not need to reach the page limitation; however, it must justify the request from the scientific perspective and describe technical design approaches with enough details to make clear the merits of the overall project.

The Scientific Justification section: This section should make clear the needs for the improvement to the physical infrastructure for HIV/AIDS research.

The text should include an overview of HIV/AIDS research programs and the research spaces available for these activities at the institution. The applicant should outline the breadth of local or regional collaborations involved in these projects. Currently active HIV/AIDS research projects funded by NIH to the applicant institution are not an eligibility requirement, but if available, they should be included in this project justification along with funding from other sources, including other federal agencies, private foundations, and institutional research support, to illustrate present needs and establish a base for future demands. If NIH research funding for HIV/AIDS projects is not available, the applicant should outline the presently undertaken efforts towards the advancement of HIV/AIDS research and relate these efforts to the long-term growth plans. Deficits in the available research infrastructure and plans to address them should be a part of the justification for the new infrastructure. This justification should be specific about the HIV/AIDS research sub-field(s) to be supported and address the relevant expertise and other available resources on which plans for the research expansion are built. To summarize this narrative, Table 3 in Other Attachments may be referenced. Current research operations should be linked to anticipated future activities, as the proposed infrastructure improvements should offer long-term benefits for the conduct of HIV/AIDS research. It should be made clear how the proposed improvements will impact and enhance future HIV/AIDS research activities.

Without duplicating information in biosketches, this section should conclude with a paragraph about the qualifications of the PD/PI to lead the construction/ modernization project from conception to completion, by working with Key Personnel on overseeing the planning process and its execution see Senior/Key Person Profile Expanded Section. It is important for the PD/PI to document that the team has the expertise and skills necessary to design and construct the facility to meet the project objectives. The text should outline the qualifications of a construction Project Manager to oversee the technical aspect of the project and present the administrative and communication plan between that person and other team members for the duration of construction, inspection, and commissioning of the facility. This section should also include qualifications of the Facility Manager (if different than the PD/PI), administrative approach to managing the facility, and communication plan with appropriate level institutional officials.

The Development of the Facility section: This section should present details of the architectural and engineering designs, their technical specifications, and proposed construction processes to support the research activities. The PD/PI should delineate implementation plans of the project, including any technical and practical challenges that will need to be overcome.

This narrative should start with the description of the location of the structures and the facilities that are affected by this project, and their placement in relation to other buildings in the immediate area. The design specifications must meet the requirements set by research needs and related processes and operating procedures described in the Scientific Justification section. The level of detail of the application's Line Drawings, data in Tables 1 and 2 in Other Attachments, and the narrative of this section, must provide sufficient information for reviewers to determine the functionality of the overall design plans and the safety and reliability of the proposed facilities. Similarly, the narrative should justify all requested fixed equipment by its relevance to the function of the facility. Also, the mechanical, electrical, and plumbing (MEP) specifications for all fixed equipment should be presented - compare data in Table 2 in the Other Attachments section. The facility should be designed to current engineering standards that will ensure the construction of a fully functional and operational facility.

The PD/PI should provide engineering and architectural design criteria relevant to the proposed project, such as:

  • MEP specifications such as hot and cold water and steam requirements; number of air exchanges per hour and heating, cooling, and ventilation requirements;
  • Fire protection requirements; building automation systems; security/surveillance;
  • Biohazard and radiation safety requirements; chemicals used;
  • Width of corridors and doors and surface finishes;
  • Quality of life issues (e.g., light levels, natural lighting, noise, vibration);
  • Access and egress routes;
  • Structural specifications for elements such as buildings, their roofs, fences, loading docks, etc.;
  • Functional relationships and zoning of the area.

All these criteria should be justified in the context of the specific function of the requested facility and explain how the requirements for HIV/AIDS research that align with NIH-established priorities will be met. Construction design for the NIH-funded facilities shall conform to the latest edition of the NIH Design Requirements Manual (DRM).

Whenever practicable, the applicant should employ sustainable design practices and green technologies. Sustainability is the outcome of an integrated process of facility development and operation, incorporating a balance of life-cycle cost, environmental impact, and occupant health, safety, security, and productivity. The following primary elements of sustainable design should be discussed, as applicable:

  • Optimization of energy use;
  • Protection and conservation of indoor and outdoor water (e.g., fixtures that reduce the amount of water used; recycling of wastewater, natural site drainage, and low impact stormwater retention);
  • Indoor environmental quality, including ventilation and thermal comfort, humidity control, and day lighting;
  • Reducing the environmental impact of materials by using low-emitting materials and minimizing use of ozone depleting compounds, construction waste reuse and recycling, maximizing recycled and bio-based content.
SF424(R&R) Senior/Key Person Profile Expanded

All instructions in the SF424 (R&R) Application Guide must be followed.

The following additional instructions apply:

The PD/PI must recruit Key Personnel with complementary technical and scientific skills.

The PD/PI should be a PhD-level scientist who has a vested interest in the success of the project; for example, a College Dean who oversees research space, Director of an Institute or Center, or a Scientific Director of a Core Facility.

An individual with technical proficiency in engineering or architectural matters related to the design and oversight of the technical aspect of the operation of the facilities must be identified for this application. This person, the construction Project Manager (Facilities Person), will closely work with the PD/PI and an outside consulting firm on all technical aspect of the projects. This person's responsibility will include oversight of the design, implementation of the project, and communication between the scientific and technical staff at every step of the development of the application and subsequent execution of the project. The role for this person in the project should be specified as "Other" or #34;Other Professional" and a biosketch with relevant information about professional qualifications and expertise must be attached.

If support for a specialized facility is requested (e.g., a barrier space to support particular protocols or animal research facilities), the team must also include a PhD-level scientist, the Facility Manager, with experience in managing facilities that support HIV/AIDS research. The PD/PI may serve in this role. This person will be tasked with communicating with other Key Personnel about specific research-driven scientific requirements for the design and construction of the facility.

SF424C Budget Information for Construction Programs

All instructions in the SF424 (R&R) Application Guide must be followed.

The following additional instructions apply:

The Budget Information for Construction Programs (SF424C) must be used to attach an overall application budget page for the total requested funds.

Applicants must provide the Total Federal Funds Requested , Total Federal and Non-Federal Funds , and Estimated Program Income on the SF424 (R&R) Cover form.

PHS 398 Cover Page Supplement
All instructions in the SF424 (R&R) Application Guide must be followed.
PHS Assignment Request Form
All instructions in the SF424 (R&R) Application Guide must be followed.

3. Unique Entity Identifier and System for Award Management (SAM)

See Part 1. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and

4. Submission Dates and Times

Part I. Overview Information contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday , the application deadline is automatically extended to the next business day.

Organizations must submit applications to (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to on or before the application due date and time. If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission.

Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.

Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.

5. Intergovernmental Review (E.O. 12372)

This initiative is not subject to intergovernmental review.

6. Funding Restrictions

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement .

Pre-award costs are allowable only as described in the NIH Grants Policy Statement.

Funds will be awarded in a single action using a sixty-month budget and project period. The requested budget can support design, construction activity and purchase of fixed equipment and its installation costs. The fixed equipment may include infrastructure equipment, such as HVAC units serving the facility and other large fixed equipment connected to the building structure and services. Also, requests can be made for fixed laboratory equipment and its installation costs. Examples of such equipment include, but are not limited to:

  • fume hoods and laminar flow stations;
  • biosafety cabinets;
  • fixed casework and laboratory benches;
  • autoclaves and other sterilizing equipment.

Allowable costs also include:

  • appraisals;
  • bid advertising;
  • inspection and commissioning fees;
  • project management;
  • contingency fees (Allowable contingency fees are limited to 15 percent of the total allowable costs before bids are received and must be reduced to 10 percent after a construction contract has been awarded.);
  • filing fees for recording of Notice of Federal Interest (NFI).

Not-allowable costs include:

  • personnel costs not related to actual construction;
  • bonus payments to contractors;
  • consultant fees not related to actual construction;
  • damage judgement suits;
  • movable equipment and furniture;
  • scientific instruments (e.g., microscopes, biomedical imagers, spectrometers);
  • FDA approval process following the completion of the construction project;
  • F&A costs;
  • supplies;
  • fund-raising expenses;
  • interior and exterior decorating fees (e.g., purchase of artwork, sculpture, etc.).

To protect the federal interest in improved real property, grantees will be required to file a Notice of Federal Interest (NFI) in the Land Record Office of the jurisdiction where the facility will be located as required by 45 CFR 75.323 and the NIH Grant Policy Statement. The NFI is required when use and disposition conditions apply to the property as stated in the NoA. The time of recordation shall be when construction begins. A copy of the recorded NFI must be provided to the Grants Management Office within 10 days following the date of recordation - see Section VII Agency Contacts. Funds will be awarded in a single action using a sixty-month budget and project period.

If awarded, all funds will be restricted except for Project Design and Engineering Fees. NIH must approve the design documents before releasing the restricted funds. The awardee will be asked to submit the design documents for technical review, in agreement with the DRM. The purpose of the NIH design review is to ensure that applicable design standards are incorporated into the drawings and specifications so that the program requirements can be met. It is expected that the technical review process will be conducted in three stages for:

Schematic Design Documents (SDDs) (15-30%),

Development Design Documents (DDDs) (50-65%), and

Construction Design Documents (CDDs) (95-100%).

Review at each stage may take 4 6 weeks. The applicant must submit SDDs within 4 months following the receipt of the Notice of Award (NoA), but considering the overall technical review timeline, the earliest possible submission of the design documents is encouraged following the receipt of the NoA.

The Environmental Analysis Form is not required at the time of the application submission. Instead, a Grants Management Specialist will request this information as part of the Just-in-Time process (NOT-OD-10-120).

7. Other Submission Requirements and Information

Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide. Paper applications will not be accepted.

Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.

For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply Application Guide. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission, contact the Application Submission Contacts in Section VII.

Important reminders:

All PD/PI must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile Component of the SF424(R&R) Application Package. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH.

The applicant organization must ensure that the DUNS number it provides on the application is the same number used in the organization’s profile in the eRA Commons and for the System for Award Management (SAM). Additional information may be found in the SF424 (R&R) Application Guide.

See more tips for avoiding common errors.

Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review, NIH. Applications that are incomplete or non-compliant will not be reviewed.

Post Submission Materials
Applicants are required to follow the instructions for post-submission materials, as described in the policy. Any instructions provided here are in addition to the instructions in the policy.

Section V. Application Review Information

1. Criteria

Applications submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review system.

Overall Impact

Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).

Scored Review Criteria

Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.

Scientific Merit and Organization of the Total Program and Its Component Parts to be Carried Out in the Facility

Does the applicant provide sufficient evidence of meritorious HIV/AIDS research program(s) that will benefit from completion of the project? How well are the component parts of the research program (that will be carried out in the facility) coordinated and managed? How will the proposed repair, renovation, or modernization activity facilitate the applicant institution’s ability to conduct, expand, improve, or maintain HIV/AIDS biomedical or behavioral research?

Is there sufficient justification for improving this core facility? To what extent will the proposed change in the research environment facilitate the applicant institution’s ability to conduct, expand, improve, or maintain HIV/AIDS biomedical or behavioral research? How will the proposed repair, renovation, or modernization activity increase efficiency in the use of energy, water, and/or materials to reduce adverse effects on the environment?

How will the project align with the institutional long-terms plans for support and advancement of HIV/AIDS research that arise from the currently present research capacities? How will the project benefit underrepresented or underserved populations?

Administrative and Leadership Capabilities of the Applicant’s Officers and Staff

How effective is the facility manager likely to be, based on 1) the administrative approach to managing the facility, 2) the ability to interact with appropriate institutional officials to see that the ongoing needs of the facility are satisfied, and 3) the skills necessary to complete the project on time and within budget?

How effective is the PD/PI likely to be, based on 1) leadership qualities and experience, 2) institutional commitment and support, and 3) the appropriate scientific and fiscal administration skills necessary to complete this project on time and within budget? Does the applicant provide evidence of future commitment in maintaining this facility?

Does the applicant institution provide evidence of future commitment in maintaining this facility?

Anticipated Effect of the Project on Other Relevant Research Programs and Facilities in the Geographic Area and Nationwide

How likely is the proposed activity to benefit HIV/AIDS research at other institutions in the local geographic area, given the availability or absence of similar or related facilities? In which ways is the proposed activity likely to affect similar or related national facilities or benefit research nationwide?

How likely is the proposed infrastructure improvement to expand HIV/AIDS research capacity addressing problems of special relevance for underserved or underrepresented communities? How will the proposed project resolve currently present infrastructure deficiencies at the applicant institution? How likely is the proposed project to serve as a foundation to expand future HIV/AIDS research?

Need for the Project or Additional Space

How compelling are: 1) the identified need(s) in the HIV/AIDS research capabilities in the applicant organization and elsewhere that the proposed repair, renovation, or modernization activity is intended to address; 2) tangible benefits to the institutional research capability of the proposed activity; and 3) state-of-the-art research capabilities or efficiencies that would otherwise not be available?

Are requests for equipment justified and of direct benefit to the HIV/AIDS research? Will the requested equipment remedy identified deficiencies or fill gaps in the animal facility?

Project Design

Design Plan: How likely is the design plan to meet the identified need(s), based on: 1) proposed demolition areas and/or renovation areas, including associated room adjacencies, traffic patterns for the movement of people, animals, and materials (clean and dirty) through the facility, and relative location of needed ancillary areas (e.g., changing rooms for animal facilities); 2) total net and gross square feet of space to be renovated; 3) proposed timeline and sequence of construction; 4) potential problems, alternative strategies, and benchmarks for success presented; and 5) implement sustainable design principles?

Engineering Criteria: How likely are the engineering systems to meet the identified need(s), based on: 1) the engineering criteria, including information about the mechanical, electrical, and plumbing systems, and utilities in the renovation; 2) descriptions of changes or additions to existing mechanical and electrical systems; and 3) the number of air changes per hour, electrical power, light levels, hot and cold water, and steam?

Architectural Criteria: How likely are the architectural criteria and finishes to meet the identified need(s), based on: 1) the size dimensions, function, and net and gross square feet for each component; 2) architectural criteria such as the width of corridors and doors and surface finishes for the project; and 3) quality of life issues (e.g., natural lighting, noise, vibration)?

Line Drawings: How likely are the line drawings to meet the identified need(s), based on: 1) the indicated function of the space; 2) the scale of the line drawings, and indication of adjacencies and operational relationships of equipment; 3) changes to be made to the space; and 4) location of major equipment, fume hoods, sinks, showers, and other major items indicated in the drawings?

Does the proposed design meet the engineering criteria for a research space to support HIV/AIDS research?

Additional Review Criteria
As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items.

Protections for Human Subjects

Generally not applicable. Reviewers should bring any concerns to the attention of the Scientific Review Officer.

Inclusion of Women, Minorities, and Individuals Across the Lifespan

Generally not applicable. Reviewers should bring any concerns to the attention of the Scientific Review Officer.

Vertebrate Animals

Generally not applicable. Reviewers should bring any concerns to the attention of the Scientific Review Officer.


Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.


Not Applicable


Not Applicable


Not Applicable

Additional Review Considerations

As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.

Applications from Foreign Organizations

Not Applicable

Select Agent Research

Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).

Resource Sharing Plans

Generally not applicable. Reviewers should bring any concerns to the attention of the Scientific Review Officer.

Budget and Period of Support

Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.

2. Review and Selection Process

Applications will be evaluated by (an) appropriate Scientific Review Group(s), convened by the Center for Scientific Review, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.

As part of the scientific peer review, all applications:

  • May undergo a selection process in which only those applications deemed to have the merit (generally the top half of applications under review) will be discussed and assigned an overall impact score.
  • Will receive a written critique.

Applications will be assigned on the basis of established PHS referral guidelines to the appropriate NIH Institute or Center. Applications will compete for available funds with all other recommended applications submitted in response to this FOA. Following initial peer review, recommended applications will receive a second level of review by the Council of Councils. The following will be considered in making funding decisions:

  • Impact score assigned to the application by the NIH peer review group
  • Relevance of the project for which construction is proposed to the objectives and priorities of the particular program authorized by the Public Health Service Act
  • Scientific merit of the research activities that will be carried out in the proposed facility
  • Scientific or professional standing or reputation of the applicant and of its existing or proposed officers and research staff
  • Availability, by affiliation or other association, of other scientific or health personnel and facilities to the extent necessary to carry out effectively the program proposed for the facility, including the adequacy of an acceptable biohazard control and containment program when warranted
  • The need for the facility and its total effects on similar or related facilities in the locale, and the need for appropriate geographic distribution of similar facilities
  • The project cost and design
  • Availability of funds.
  • The geographical location of the facilities.
  • The ability of the facility to stimulate additional research activities related to HIV/AIDS research.
  • The financial need of the applicant

3. Anticipated Announcement and Award Dates

After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons. Refer to Part 1 for dates for peer review, advisory council review, and earliest start date.

Information regarding the disposition of applications is available in the NIH Grants Policy Statement.

Section VI. Award Administration Information

1. Award Notices

If the application is under consideration for funding, NIH will request "just-in-time" information from the applicant as described in the NIH Grants Policy Statement.

A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization for successful applications. The NoA signed by the grants management officer is the authorizing document and will be sent via email to the grantee’s business official.

Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.

Any application awarded in response to this FOA will be subject to terms and conditions found on the Award Conditions and Information for NIH Grants website. This includes any recent legislation and policy applicable to awards that is highlighted on this website.

2. Administrative and National Policy Requirements

All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Recipients, and Activities. More information is provided at Award Conditions and Information for NIH Grants.

Recipients of federal financial assistance (FFA) from HHS must administer their programs in compliance with federal civil rights laws that prohibit discrimination on the basis of race, color, national origin, disability, age and, in some circumstances, religion, conscience, and sex. This includes ensuring programs are accessible to persons with limited English proficiency. The HHS Office for Civil Rights provides guidance on complying with civil rights laws enforced by HHS. Please see and

HHS recognizes that research projects are often limited in scope for many reasons that are nondiscriminatory, such as the principal investigator’s scientific interest, funding limitations, recruitment requirements, and other considerations. Thus, criteria in research protocols that target or exclude certain populations are warranted where nondiscriminatory justifications establish that such criteria are appropriate with respect to the health or safety of the subjects, the scientific study design, or the purpose of the research. For additional guidance regarding how the provisions apply to NIH grant programs, please contact the Scientific/Research Contact that is identified in Section VII under Agency Contacts of this FOA.

Please contact the HHS Office for Civil Rights for more information about obligations and prohibitions under federal civil rights laws at or call 1-800-368-1019 or TDD 1-800-537-7697.

In accordance with the statutory provisions contained in Section 872 of the Duncan Hunter National Defense Authorization Act of Fiscal Year 2009 (Public Law 110-417), NIH awards will be subject to the Federal Awardee Performance and Integrity Information System (FAPIIS) requirements. FAPIIS requires Federal award making officials to review and consider information about an applicant in the designated integrity and performance system (currently FAPIIS) prior to making an award. An applicant, at its option, may review information in the designated integrity and performance systems accessible through FAPIIS and comment on any information about itself that a Federal agency previously entered and is currently in FAPIIS. The Federal awarding agency will consider any comments by the applicant, in addition to other information in FAPIIS, in making a judgement about the applicant’s integrity, business ethics, and record of performance under Federal awards when completing the review of risk posed by applicants as described in 45 CFR Part 75.205 Federal awarding agency review of risk posed by applicants. This provision will apply to all NIH grants and cooperative agreements except fellowships.

Cooperative Agreement Terms and Conditions of Award

Not Applicable

3. Reporting

Progress reports for multiyear funded awards are due annually on or before the anniversary of the budget/project period start date of award. The reporting period for multiyear funded award progress report is the calendar year preceding the anniversary date of the award. Information on the content of the progress report and instructions on how to submit the report are posted at

A final RPPR, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement. Following completion and occupancy of the facility, recipients must certify on a yearly basis for 20 years that the facility is used to conduct biomedical research.

The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at on all subawards over $25,000. See the NIH Grants Policy Statement for additional information on this reporting requirement.

In accordance with the regulatory requirements provided at 45 CFR 75.113 and Appendix XII to 45 CFR Part 75, recipients that have currently active Federal grants, cooperative agreements, and procurement contracts from all Federal awarding agencies with a cumulative total value greater than $10,000,000 for any period of time during the period of performance of a Federal award, must report and maintain the currency of information reported in the System for Award Management (SAM) about civil, criminal, and administrative proceedings in connection with the award or performance of a Federal award that reached final disposition within the most recent five-year period. The recipient must also make semiannual disclosures regarding such proceedings. Proceedings information will be made publicly available in the designated integrity and performance system (currently FAPIIS). This is a statutory requirement under section 872 of Public Law 110-417, as amended (41 U.S.C. 2313). As required by section 3010 of Public Law 111-212, all information posted in the designated integrity and performance system on or after April 15, 2011, except past performance reviews required for Federal procurement contracts, will be publicly available. Full reporting requirements and procedures are found in Appendix XII to 45 CFR Part 75 Award Term and Conditions for Recipient Integrity and Performance Matters

Section VII. Agency Contacts

We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.

Application Submission Contacts

eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues)

Finding Help Online: (preferred method of contact)
Telephone: 301-402-7469 or 866-504-9552 (Toll Free)

General Grants Information (Questions regarding application instructions, application processes, and NIH grant resources)
Email: (preferred method of contact)
Telephone: 301-945-7573 Customer Support (Questions regarding registration and Workspace)
Contact Center Telephone: 800-518-4726

Scientific/Research Contact(s)

Guanghu Wang, Ph.D., M.B.A
Office of Research Infrastructure Programs (ORIP)
Telephone: 301-435-0772

Brenda Fredericksen, Ph.D.
Office of AIDS Research (OAR)
Telephone: 240-669-5566

Peer Review Contact(s)

Mark Caprara, Ph.D.
Center for Scientific Review (CSR)
Telephone: 301-613-5228

Financial/Grants Management Contact(s)

Gavin Wilkom, M.I.M
National Heart, Lung, and Blood Institute (NHLBI)
Office of Research Infrastructure Programs (ORIP)
Telephone: 301-827-7078

Section VIII. Other Information

Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Authority and Regulations

Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284), 42 USC 283k, and under Federal Regulations 42 CFR Part 52b and 45 CFR Part 75.

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS) - Government Made Easy
NIH... Turning Discovery Into Health®